OSL — Oncosil Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$23.03m
- AU$14.64m
- AU$0.58m
Annual cashflow statement for Oncosil Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 3.91 | 2.99 | 0.842 | 0.884 | 1.17 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.46 | -8.82 | -10.1 | -11.3 | -10.8 |
| Capital Expenditures | -0.021 | -0.054 | -0.006 | -0.058 | -0.197 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.021 | -0.054 | -0.006 | -0.058 | -0.197 |
| Financing Cash Flow Items | -1.22 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.8 | 0.111 | 9.16 | 9.49 | 6.13 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.3 | -8.76 | -0.96 | -1.89 | -4.89 |